Synaesthesia, a neurological condition associated with anxiety disorders and autism, is difficult to identify in children. The EU-funded SYN-TOOLKIT project developed a new method to gather evidence of this perceptual phenomenon. The research has led to the development of a diagnostic smartphone app that could help these individuals access support.
The potential for mRNA goes well beyond the COVID-19 vaccine. With the support of the EU-funded MOSaIC project, one research centre in Poland is conducting cutting-edge research in the field, paving the way for new treatments against diseases such as cancer, Alzheimer’s and genetic conditions.
Miniature medical devices have the potential to screen, monitor, diagnose and treat a range of body functions, conditions and diseases. But implanting these devices into the body requires safe, non-toxic materials. The biocompatible materials developed by the EU-funded BioWings project could open the door to a new era of medical innovation for EU citizens and the world.
It was assumed that viruses spread as independent particles called virions. The EU-funded Vis-a-Vis project used social evolution concepts to study viral transmission, showing how viral particles compete and collaborate with one another. An improved understanding of virus-virus interactions paves the way for a new generation of treatments.
Ovarian cancer is often diagnosed too late for treatments to work. The EU-funded EARLYDETECT project developed innovative screening tools capable of detecting the disease early.
This will help patients receive the therapies they need sooner, before the disease spreads, saving the lives of citizens in the EU and beyond.
Many implants can be rejected from the body if the bone doesn’t heal around them properly. The EU-funded BoneImplant project developed new ways to quantify implant status and improve their overall success rate. The research will directly improve the quality of life of EU citizens.
A rare infectious disease that can cause permanent blindness may soon have an approved treatment for the first time. A formulation of the molecule polihexanide, optimised by the EU-funded ODAK project, has been shown to cure 87 % of patients. The drug will soon be available to patients across Europe through an early access programme.
The effectiveness of photodynamic therapy is limited by the lack of oxygen in solid cancers. Now, EU-funded researchers have developed drug delivery nano-carriers to bring oxygen to the tumour site. This strategy could improve the effectiveness of this photodynamic therapy and help to save the lives of citizens affected by cancer.
Cancer and neglected tropical diseases impact millions of people every year. By identifying compounds that specifically target affected cells, EU-funded researchers have opened the door to potential new treatments. These medicines could save lives and benefit citizens both in Europe and around the world.
While researchers were busy developing a handheld device to rapidly detect biomarkers to guide the therapy in lung cancer, the pandemic struck. Realising their device could be adapted to test for coronavirus, researchers refocused their work. The result is the market’s smallest portable PCR device.
